Global Organ Transplant Diagnostics Market Growth (Status and Outlook) 2023-2029

Global Organ Transplant Diagnostics Market Growth (Status and Outlook) 2023-2029

Demand for transplant diagnostic products is expected to increase, mainly due to factors such as increased public-private partnership funding for targeted research activities, increased burden of infectious diseases, increased number of transplant procedures, and technological advancements in the field of transplant diagnostics. The market segment by technology is divided into molecular and non-molecular analytical technologies. The field of molecular analysis technology has the largest market share. A large part of this part can be attributed to the benefits of molecular detection, such as short turnaround time, high program efficiency, research on multiple samples, and real-time sample analysis.

LPI (LP Information)' newest research report, the “Organ Transplant Diagnostics Industry Forecast” looks at past sales and reviews total world Organ Transplant Diagnostics sales in 2022, providing a comprehensive analysis by region and market sector of projected Organ Transplant Diagnostics sales for 2023 through 2029. With Organ Transplant Diagnostics sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Organ Transplant Diagnostics industry.

This Insight Report provides a comprehensive analysis of the global Organ Transplant Diagnostics landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Organ Transplant Diagnostics portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Organ Transplant Diagnostics market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Organ Transplant Diagnostics and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Organ Transplant Diagnostics.

The global Organ Transplant Diagnostics market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.

United States market for Organ Transplant Diagnostics is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.

China market for Organ Transplant Diagnostics is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.

Europe market for Organ Transplant Diagnostics is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.

Global key Organ Transplant Diagnostics players cover QIAGEN NV, Thermo Fisher Scientific, BioMérieuxSA, CareDx, Luminex Corporation, Dickinson and Company and Biofortuna, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.

This report presents a comprehensive overview, market shares, and growth opportunities of Organ Transplant Diagnostics market by product type, application, key players and key regions and countries.

Market Segmentation:

Segmentation by type
Molecular Assay Technologies
Non-molecular Assay Technologies

Segmentation by application
Independent Reference Laboratories
Hospitals and Transplant Centers
Research Laboratories and Academic Institutes

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
QIAGEN NV
Thermo Fisher Scientific
BioMérieuxSA
CareDx
Luminex Corporation
Dickinson and Company
Biofortuna

Please note: The report will take approximately 2 business days to prepare and deliver.